From: Efficacy of orally and topically administered fluralaner (Bravecto®) for treatment of client-owned dogs with sarcoptic mange under field conditions
Day 28
Day 56
Day 84
Oral fluralaner
(n = 54)
94.4%
100%
Topical fluralaner
(n = 46)
95.7%
Oral sarolaner
(n = 26)
92.3%